Identification of CD90 as Putative Cancer Stem Cell Marker and Therapeutic Target in Insulinomas

The long-term prognosis after surgical resection of malignant insulinoma (INS) is poor. Novel adjuvant therapies, specifically targeting cancer stem cells (CSCs), are warranted. Therefore, the goal of this study was to characterize and target putative INS CSCs. Using fluorescence-activated cell sort...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Stem Cells Dev
Main Authors: Buishand, Floryne O., Arkesteijn, Ger J.A., Feenstra, Laurien R., Oorsprong, Claire W.D., Mestemaker, Margiet, Starke, Achim, Speel, Ernst-Jan M., Kirpensteijn, Jolle, Mol, Jan A.
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc. 2016
Assuntos:
Original Research Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4892226/
https://ncbi.nlm.nih.gov/pubmed/27049037
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/scd.2016.0032
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados